Engineering a Novel Bivalent Oral Vaccine against Enteric Fever

Enteric fever is a major global healthcare issue caused largely by Salmonella enterica serovars Typhi and Paratyphi A. The objective of this study was to develop a novel, bivalent oral vaccine capable of protecting against both serovars. Our approach centred on genetically engineering the attenuated...

Descripción completa

Detalles Bibliográficos
Autores principales: Soulier, Annelise, Prevosto, Claudia, Chol, Mary, Deban, Livija, Cranenburgh, Rocky M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005139/
https://www.ncbi.nlm.nih.gov/pubmed/33807097
http://dx.doi.org/10.3390/ijms22063287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005139/
https://www.ncbi.nlm.nih.gov/pubmed/33807097
http://dx.doi.org/10.3390/ijms22063287

Ejemplares similares